13F filer · CIK 1597549
Iguana Healthcare Management, LLC
New York, NY · filing since Q4 2013 · last filing May 15, 2018
Reported value
$245.8M
$-27.1M vs prior
Positions
82
New / sold out
41 / 34
Added / reduced
15 / 17
Turnover
42.6%
buys $110.4M · sells $151.7M
Top-10 weight
37.0%
Biggest buys vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | SHIRE PLC | +60,000 | – | +$11.0M |
| New | ANTHEM INC | +70,000 | – | +$9.2M |
| New | ALEXION PHARMACEUTICALS INC | +50,000 | – | +$5.8M |
| New | ALEXION PHARMACEUTICALS INCCALL | +50,000 | – | +$5.8M |
| New | MEDICINES COCALL | +140,000 | – | +$4.7M |
| Added | GILEAD SCIENCES INC | +50,000 | +58.8% | +$4.2M |
| New | LILLY ELI & COPUT | +50,000 | – | +$3.9M |
| New | ILLUMINA INC | +25,000 | – | +$3.5M |
| New | CIGNA CORPORATIONCALL | +25,000 | – | +$3.2M |
| New | ABBVIE INCCALL | +50,000 | – | +$3.1M |
46 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2016
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Reduced | MEDIVATION | -255,000 | -96.2% | $-15.4M |
| Sold out | CIGNA CORPORATION | -100,000 | -100.0% | $-13.7M |
| Sold out | SPDR SERIES TRUSTPUT | -250,000 | -100.0% | $-12.9M |
| Sold out | ISHARES TRPUT | -100,000 | -100.0% | $-11.1M |
| Sold out | SPDR S&P 500 ETF TRPUT | -50,000 | -100.0% | $-10.3M |
| Sold out | MEDTRONIC PLC | -100,000 | -100.0% | $-7.5M |
| Reduced | BAXTER INTL INC | -155,000 | -53.4% | $-7.0M |
| Sold out | LLYLILLY ELI & CO | -75,000 | -100.0% | $-5.4M |
| Sold out | BIOGEN INCCALL | -20,000 | -100.0% | $-5.2M |
| Reduced | CELGENE CORP | -50,000 | -28.6% | $-4.9M |
41 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2016
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | CELGENE CORPCOM | 125,000 | $12.3M | 5.02% |
| 2 | ZIMMER BIOMET HLDGS INCCOM | 100,000 | $12.0M | 4.90% |
| 3 | GILEAD SCIENCES INCCOM | 135,000 | $11.3M | 4.58% |
| 4 | SHIRE PLCSPONSORED ADR | 60,000 | $11.0M | 4.49% |
| 5 | ANTHEM INCCOM | 70,000 | $9.2M | 3.74% |
| 6 | ONCOMED PHARMACEUTICALS INCCOM | 632,200 | $7.8M | 3.17% |
| 7 | MERCK & CO INCCOM | 125,000 | $7.2M | 2.93% |
| 8 | PFIZER INCCOM | 200,000 | $7.0M | 2.86% |
| 9 | ULTRAGENYX PHARMACEUTICAL INCOM | 140,000 | $6.8M | 2.79% |
| 10 | BAXTER INTL INCCOM | 135,000 | $6.1M | 2.48% |
72 more rows. Subscribe for $29/month to see every row, download the data and use the API.